Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POWER Point of Care Effect on Satisfaction of Treatment
NCT00549068Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of risedronate in postmenopausal osteoporosis, sponsored by Sanofi. Started Feb 2003; status: completed.
02
Drugs
risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00549068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549068.